Abstract
1 Tiamenidine (Hoe 440) is an imidazoline with blood pressure lowering properties. Its pharmacology resembles that of clonidine. 2 The effect of both drugs on blood pressure, plasma noradrenaline (NA), plasma adrenaline (Ad), urinary catecholamines and plasma renin activity (PRA) was assessed in four previously untreated male hypertensive patients in a cross over study. 3 The maximum daily dose of tiamenidine was 3 mg. The maximum daily dose of clonidine was 450 micrograms. 4 During treatment, blood pressure, systolic and diastolic, supine and erect, fell on average between 12 and 15%. Levels of NA, Ad, PRA were reduced during treatment. 5 During withdrawal of either drug there was rebound of blood pressure and NA, Ad, PRA, overshooting baseline levels. 6 The withdrawal effects caused by clonidine were similar for tiamenidine.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Collier J. G., Dawnay N. A., Nachev C., Robinson B. F. Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A. Br J Pharmacol. 1972 Feb;44(2):286–293. doi: 10.1111/j.1476-5381.1972.tb07265.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Engelman K., Portnoy B. A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Normal resting human plasma levels. Circ Res. 1970 Jan;26(1):53–57. doi: 10.1161/01.res.26.1.53. [DOI] [PubMed] [Google Scholar]
- Geyskes G. G., Boer P., Dorhout Mees E. J. Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Br J Clin Pharmacol. 1979 Jan;7(1):55–62. doi: 10.1111/j.1365-2125.1979.tb00897.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldberg A. D., Wilkinson P. R., Raftery E. B. The over-shoot phenomenon on withdrawal of clonidine therapy. Postgrad Med J. 1976;52 (Suppl 7):128–136. [PubMed] [Google Scholar]
- Hökfelt B., Hedeland H., Dymling J. F. Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients. Eur J Pharmacol. 1970;10(3):389–397. doi: 10.1016/0014-2999(70)90212-8. [DOI] [PubMed] [Google Scholar]
- Lindner E., Kaiser J. Tiamenidine (Hoe 440), a new antihypertensive substance. Arch Int Pharmacodyn Ther. 1974 Oct;211(2):305–325. [PubMed] [Google Scholar]
- Lindner E., Schölkens B. A. Zentrale Gaben von Tiamenidin und Clonidin bei normotonen und chronisch renal hypertonen Tieren. Verh Dtsch Ges Kreislaufforsch. 1977;43:234–234. [PubMed] [Google Scholar]
- Reid J. L., Wing L. M., Dargie H. J., Hamilton C. A., Davies D. S., Dollery C. T. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet. 1977 Jun 4;1(8023):1171–1174. doi: 10.1016/s0140-6736(77)92715-5. [DOI] [PubMed] [Google Scholar]
- von EULER U., LISHAJKO F. Improved technique for the fluorimetric estimation of catecholamines. Acta Physiol Scand. 1961 Apr;51:348–355. doi: 10.1111/j.1748-1716.1961.tb02128.x. [DOI] [PubMed] [Google Scholar]